Cite
HARVARD Citation
Bocquet, O. et al. (2021). Adverse Effects of Oseltamivir Phosphate Therapy on the Liver of LDLR−/− Mice Without Any Benefit on Atherosclerosis and Thrombosis. Journal of cardiovascular pharmacology. 77 (5), p. . [Online].